We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Nutritional Intervention for Cancer

By Biotechdaily staff writers
Posted on 22 Nov 2005
Altering the diet of a patient with lung cancer has been able to shrink cancerous tumors to 10% of their size and prolong the patient's life.

Ron Pardini, a professor of biochemistry and associate director of the Nevada Agricultural Experiment Station at the University of Nevada, Reno (USA), has conducted research that shows omega-3 fatty acids can depress the growth of human mammary, ovarian, colon, prostate and pancreatic cancer cells that are injected into athymic mice, also known as nude mice. More...
Other studies demonstrated that fish oil consumption improved a mouse's responsiveness to chemotherapy. This research was inspired by the observation that Inuit Eskimo populations have fewer breast and prostate cancer deaths.

When a neighbor was diagnosed with terminal lung cancer, Dr. Pardini sprang into action, radically changing the neighbor's diet. He reduced the corn-based foods in the patient's diet, because corn contains omega-6 fatty acids that have been found to increase cancer growth. Instead, he drastically increased the patient's intake of fish oil and golden algae oil capsules daily. Five years later, the patient is still alive and has gained some weight.

"We have good evidence for employing nutritional interventions to improve cancer treatments and patient well-being,” said Dr. Pardini.

An article on nutritional intervention was published in the Nutrition and Cancer journal (2005,52;2:121-127), co-authored by Dr. Pardini and colleagues.




Related Links:
University of Nevada

Gold Member
Quality Control Material
iPLEX Pro Exome QC Panel
New
Gold Member
Automatic Hematology Analyzer
CF9600
New
Total Laboratory Automation Solution
SATLARS Mini T8
New
Automated Urinalysis Solution
UN-9000
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image

Urine-Based Multi-Cancer Screening Test Receives FDA Breakthrough Device Designation

Early detection across multiple cancers remains a major unmet need in population screening. Non-invasive approaches that can be delivered at scale may broaden access and shift diagnoses to earlier stages.... Read more

Molecular Diagnostics

view channel
Image: The new approach focuses on CpG DNA methylation, a chemical modification of cytosine and guanine bases, using tumor samples to develop a computational model that distinguishes among 21 cancer types (photo credet: 123RF)

Machine Learning Model Uses DNA Methylation to Predict Tumor Origin in Cancers of Unknown Primary

Cancers of unknown primary (CUP) are metastatic malignancies in which the primary site cannot be identified, complicating treatment selection. Many patients consequently receive broad, nonspecific chemotherapy... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.